A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

NCT00256204 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1174

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Rasagiline Mesylate
DRUG: Rasagiline Mesylate
OTHER: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.